StockGlow

Aditxt, Inc. (ADTX)

Develops blood tests to detect cancer and autoimmune diseases early using DNA markers.

$0.00-0.06%Healthcare
Compare ADTX with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-100.0%

The outlook

ADTX trades at the extreme low end of its 52-week range, well below both its 50- and 200-day moving averages. Analyst coverage appears thin or unavailable. The overall data picture reflects significant weakness with minimal upward momentum in the near term.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$3.0M
52-wk high
$31,364.28
52-wk low
$0.00
50-day avg
$0.23
200-day avg
$941.87
Trailing P/E
—

Similar stocks

ENSCEnsysce Biosciences, Inc.$0.25-5.43%RKTORocket One Inc.$0.78+1.08%ADILAdial Pharmaceuticals, Inc.$2.90+3.20%DBGIDigital Brands Group, Inc.$13.42+6.85%PALIPalisade Bio, Inc.$2.01-1.23%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy